Virtual Reality Exposure Therapy Versus Exposure in Vivo for Social Phobia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Social Anxiety Disorder
- Sponsor
- VU University of Amsterdam
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Change from baseline: Liebowitz Social Anxiety Scale-Self report
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The current study aims at comparing the efficacy of exposure in vivo and exposure via virtual reality for social anxiety disorder. 70 patients with social anxiety disorder will be randomized to either one of the active conditions or to a waiting-list condition. Participants on the waiting-list will be offered either exposure in vivo of in virtual reality after a waiting period of five weeks. Levels of psychopathology will be assessed at pre- and post-treatment as well as three and 12 months after treatment.
Investigators
Paul M.G.Emmelkamp
Professor
VU University of Amsterdam
Eligibility Criteria
Inclusion Criteria
- •18 - 65 years old
- •a primary diagnosis of social anxiety disorder as measured with the SCID
- •fluency in Dutch.
Exclusion Criteria
- •psychotic episodes in the past, suicidal intentions or substance dependence.
- •behavior therapy in the preceding one year.
Outcomes
Primary Outcomes
Change from baseline: Liebowitz Social Anxiety Scale-Self report
Time Frame: Pre-treatment to post-treatment (5 weeks), three months follow-up, and 12 months follow-up.
Change from pre-treatment to post-treatment (5 weeks), 3 months follow-up and 12 months follow-up.
Change from baseline: Fear of Negative Evaluation Scale
Time Frame: Pre-treatment to post-treatment (5 weeks), three months follow-up, and 12 months follow-up.
Change from pre-treatment to post-treatment (5 weeks), 3 months follow-up and 12 months follow-up.
Secondary Outcomes
- Change from baseline: Behavioral Assessment Task (BAT), Public Speaking Performance Scale(Pre-treatment to post-treatment (5 weeks))
- Change from baseline: Structured Clinical Interview for DSM-IV (Social Phobia Module)(Pre-treatment to three months follow-up.)
- Change from baseline: Depression Anxiety Stress Scale(Pre-treatment to post-treatment (5 weeks), three months follow-up, 12 months follow-up.)
- Change from baseline: Personality Disorder Belief Questionnaire(Pre-treatment to post-treatment (5 weeks), three months follow-up, 12 months follow-up.)
- Change from baseline: Eurohis Quality of Life Scale(Pre-treatment to post-treatment (5 weeks), three months follow-up, 12 months follow-up.)